Adapting the γ-H2AX assay for automated processing in human lymphocytes. 1. Technological aspects.
Adapting the γ-H2AX assay for automated processing in human lymphocytes. 1. Technological aspects.
复制标题
DOI:
10.1667/rr2125.1
复制
发表时间:
2011-03
影响因子:
3.4
通讯作者:
Garty G
中科院分区:
文献类型:
--
作者:
Turner HC;Brenner DJ;Chen Y;Bertucci A;Zhang J;Wang H;Lyulko OV;Xu Y;Shuryak I;Schaefer J;Simaan N;Randers-Pehrson G;Yao YL;Amundson SA;Garty G
The immunofluorescence-based detection of γ-H2AX is a reliable and sensitive method for quantitatively measuring DNA double-strand breaks (DSBs) in irradiated samples. Since H2AX phosphorylation is highly linear with radiation dose, this well-established biomarker is in current use in radiation biodosimetry. At the Center for High-Throughput Minimally Invasive Radiation Biodosimetry, we have developed a fully automated high-throughput system, the RABIT (Rapid Automated Biodosimetry Tool), that can be used to measure γ-H2AX yields from fingerstick-derived samples of blood. The RABIT workstation has been designed to fully automate the γ-H2AX immunocytochemical protocol, from the isolation of human blood lymphocytes in heparin-coated PVC capillaries to the immunolabeling of γ-H2AX protein and image acquisition to determine fluorescence yield. High throughput is achieved through the use of purpose-built robotics, lymphocyte handling in 96-well filter-bottomed plates, and high-speed imaging. The goal of the present study was to optimize and validate the performance of the RABIT system for the reproducible and quantitative detection of γ-H2AX total fluorescence in lymphocytes in a multiwell format. Validation of our biodosimetry platform was achieved by the linear detection of a dose-dependent increase in γ-H2AX fluorescence in peripheral blood samples irradiated ex vivo with γ rays over the range 0 to 8 Gy. This study demonstrates for the first time the optimization and use of our robotically based biodosimetry workstation to successfully quantify γ-H2AX total fluorescence in irradiated peripheral lymphocytes.